7.09 USD
-0.53 (-6.96%)
7.09 USD
0 (0%)
Taking everything into account, BVS scores 5 out of 10 in our fundamental rating. BVS was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While BVS is still in line with the averages on profitability rating, there are concerns on its financial health. BVS may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
BVS had positive earnings in the past year.
BVS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
BVS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.11%, BVS is in the better half of the industry, outperforming 75.66% of the companies in the same industry.
BVS's Return On Equity of 4.71% is fine compared to the rest of the industry. BVS outperforms 76.72% of its industry peers.
BVS has a better Return On Invested Capital (6.62%) than 80.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROIC | 6.62% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 1.39%, BVS is in the better half of the industry, outperforming 74.60% of the companies in the same industry.
The Operating Margin of BVS (8.03%) is better than 75.66% of its industry peers.
BVS's Operating Margin has declined in the last couple of years.
BVS has a Gross Margin of 67.76%. This is in the better half of the industry: BVS outperforms 71.96% of its industry peers.
BVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
BVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BVS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BVS has more shares outstanding
BVS has a better debt/assets ratio than last year.
2.2 Solvency
BVS has an Altman-Z score of 1.18. This is a bad value and indicates that BVS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.18, BVS is in line with its industry, outperforming 53.97% of the companies in the same industry.
The Debt to FCF ratio of BVS is 6.22, which is on the high side as it means it would take BVS, 6.22 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BVS (6.22) is better than 76.72% of its industry peers.
A Debt/Equity ratio of 1.93 is on the high side and indicates that BVS has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.93, BVS is doing worse than 80.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Altman-Z | 1.18 |
ROIC/WACC0.78
WACC8.51%
2.3 Liquidity
BVS has a Current Ratio of 1.74. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BVS (1.74) is worse than 68.78% of its industry peers.
A Quick Ratio of 1.14 indicates that BVS should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.14, BVS is not doing good in the industry: 71.96% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
BVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.28%, which is quite impressive.
The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
BVS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.58%.
Measured over the past years, BVS shows a quite strong growth in Revenue. The Revenue has been growing by 11.01% on average per year.
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
3.2 Future
BVS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.51% yearly.
Based on estimates for the next years, BVS will show a small growth in Revenue. The Revenue will grow by 4.43% on average per year.
EPS Next Y41.83%
EPS Next 2Y31.93%
EPS Next 3Y25.51%
EPS Next 5YN/A
Revenue Next Year0.33%
Revenue Next 2Y3.66%
Revenue Next 3Y4.43%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.02 indicates a correct valuation of BVS.
91.53% of the companies in the same industry are more expensive than BVS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of BVS to the average of the S&P500 Index (26.49), we can say BVS is valued rather cheaply.
The Price/Forward Earnings ratio is 8.67, which indicates a very decent valuation of BVS.
BVS's Price/Forward Earnings ratio is rather cheap when compared to the industry. BVS is cheaper than 95.24% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.69. BVS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.02 | ||
| Fwd PE | 8.67 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BVS is valued cheaper than 92.59% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BVS is valued cheaply inside the industry as 95.77% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.97 | ||
| EV/EBITDA | 9.43 |
4.3 Compensation for Growth
BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BVS's earnings are expected to grow with 25.51% in the coming years.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y31.93%
EPS Next 3Y25.51%
5. Dividend
5.1 Amount
BVS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.09
-0.53 (-6.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners74.46%
Inst Owner Change1.06%
Ins Owners2.51%
Ins Owner Change-0.23%
Market Cap586.77M
Revenue(TTM)563.83M
Net Income(TTM)7.82M
Analysts80
Price Target15.3 (115.8%)
Short Float %3.19%
Short Ratio6.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.08%
Min EPS beat(2)-0.99%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)86.47%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)133.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)4.79%
Revenue beat(8)6
Avg Revenue beat(8)4.08%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)1.33%
PT rev (1m)2.27%
PT rev (3m)2.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)3.13%
EPS NY rev (3m)2.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.02 | ||
| Fwd PE | 8.67 | ||
| P/S | 1.04 | ||
| P/FCF | 10.97 | ||
| P/OCF | 10.47 | ||
| P/B | 3.53 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.43 |
EPS(TTM)0.59
EY8.32%
EPS(NY)0.82
Fwd EY11.54%
FCF(TTM)0.65
FCFY9.11%
OCF(TTM)0.68
OCFY9.55%
SpS6.81
BVpS2.01
TBVpS-2.64
PEG (NY)0.29
PEG (5Y)N/A
Graham Number5.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROCE | 8.38% | ||
| ROIC | 6.62% | ||
| ROICexc | 7.18% | ||
| ROICexgc | 31.69% | ||
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% | ||
| FCFM | 9.48% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y44.62%
ROICexgc growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score8
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Debt/EBITDA | 3.44 | ||
| Cap/Depr | 5.36% | ||
| Cap/Sales | 0.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 60.26% | ||
| Profit Quality | 683.69% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 1.18 |
F-Score8
WACC8.51%
ROIC/WACC0.78
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y41.83%
EPS Next 2Y31.93%
EPS Next 3Y25.51%
EPS Next 5YN/A
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
Revenue Next Year0.33%
Revenue Next 2Y3.66%
Revenue Next 3Y4.43%
Revenue Next 5YN/A
EBIT growth 1Y178.93%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.21%
EBIT Next 3Y12.52%
EBIT Next 5YN/A
FCF growth 1Y29806.1%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y448.75%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%
BIOVENTUS INC - A / BVS FAQ
Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to BVS.
What is the valuation status of BIOVENTUS INC - A (BVS) stock?
ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.
Can you provide the profitability details for BIOVENTUS INC - A?
BIOVENTUS INC - A (BVS) has a profitability rating of 5 / 10.
How financially healthy is BIOVENTUS INC - A?
The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.
What is the earnings growth outlook for BIOVENTUS INC - A?
The Earnings per Share (EPS) of BIOVENTUS INC - A (BVS) is expected to grow by 41.83% in the next year.